FR2197598A1 - - Google Patents

Info

Publication number
FR2197598A1
FR2197598A1 FR7331531A FR7331531A FR2197598A1 FR 2197598 A1 FR2197598 A1 FR 2197598A1 FR 7331531 A FR7331531 A FR 7331531A FR 7331531 A FR7331531 A FR 7331531A FR 2197598 A1 FR2197598 A1 FR 2197598A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7331531A
Other languages
French (fr)
Other versions
FR2197598B1 (US20090192370A1-20090730-C00001.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2197598A1 publication Critical patent/FR2197598A1/fr
Application granted granted Critical
Publication of FR2197598B1 publication Critical patent/FR2197598B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
FR7331531A 1972-08-31 1973-08-31 Expired FR2197598B1 (US20090192370A1-20090730-C00001.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2242787A DE2242787C2 (de) 1972-08-31 1972-08-31 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2197598A1 true FR2197598A1 (US20090192370A1-20090730-C00001.png) 1974-03-29
FR2197598B1 FR2197598B1 (US20090192370A1-20090730-C00001.png) 1977-07-15

Family

ID=5855065

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7331531A Expired FR2197598B1 (US20090192370A1-20090730-C00001.png) 1972-08-31 1973-08-31

Country Status (21)

Country Link
US (1) US3925395A (US20090192370A1-20090730-C00001.png)
JP (1) JPS5626661B2 (US20090192370A1-20090730-C00001.png)
AT (1) AT327902B (US20090192370A1-20090730-C00001.png)
AU (1) AU476373B2 (US20090192370A1-20090730-C00001.png)
BE (1) BE804161A (US20090192370A1-20090730-C00001.png)
CA (1) CA1016946A (US20090192370A1-20090730-C00001.png)
CH (1) CH592061A5 (US20090192370A1-20090730-C00001.png)
DD (1) DD109628A5 (US20090192370A1-20090730-C00001.png)
DE (1) DE2242787C2 (US20090192370A1-20090730-C00001.png)
DK (1) DK131855C (US20090192370A1-20090730-C00001.png)
ES (1) ES418340A1 (US20090192370A1-20090730-C00001.png)
FR (1) FR2197598B1 (US20090192370A1-20090730-C00001.png)
GB (1) GB1389505A (US20090192370A1-20090730-C00001.png)
HU (1) HU167992B (US20090192370A1-20090730-C00001.png)
IE (1) IE38141B1 (US20090192370A1-20090730-C00001.png)
IL (1) IL43080A (US20090192370A1-20090730-C00001.png)
LU (1) LU68325A1 (US20090192370A1-20090730-C00001.png)
NL (1) NL7311832A (US20090192370A1-20090730-C00001.png)
PL (1) PL89430B1 (US20090192370A1-20090730-C00001.png)
SE (1) SE385882B (US20090192370A1-20090730-C00001.png)
ZA (1) ZA735973B (US20090192370A1-20090730-C00001.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
IT8367883A0 (it) * 1982-08-23 1983-08-22 Rorer Int Overseas Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche
WO1993009774A1 (en) * 1991-11-18 1993-05-27 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
US7230017B2 (en) 2002-08-27 2007-06-12 Bayer Healthcare Ag Dihydropyridinone derivatives
US20050252833A1 (en) * 2004-05-14 2005-11-17 Doyle James A Process and apparatus for converting oil shale or oil sand (tar sand) to oil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate

Also Published As

Publication number Publication date
CA1016946A (en) 1977-09-06
DK131855C (da) 1976-02-16
IL43080A (en) 1977-01-31
ZA735973B (en) 1974-10-30
HU167992B (US20090192370A1-20090730-C00001.png) 1976-02-28
PL89430B1 (US20090192370A1-20090730-C00001.png) 1976-11-30
LU68325A1 (US20090192370A1-20090730-C00001.png) 1973-10-30
BE804161A (fr) 1974-02-28
AU476373B2 (en) 1976-09-16
GB1389505A (en) 1975-04-03
SE385882B (sv) 1976-07-26
CH592061A5 (US20090192370A1-20090730-C00001.png) 1977-10-14
ATA760073A (de) 1975-05-15
JPS4962483A (US20090192370A1-20090730-C00001.png) 1974-06-17
DE2242787A1 (de) 1974-03-14
DE2242787C2 (de) 1982-01-21
AT327902B (de) 1976-02-25
ES418340A1 (es) 1976-03-16
IL43080A0 (en) 1973-11-28
DK131855B (da) 1975-09-15
NL7311832A (US20090192370A1-20090730-C00001.png) 1974-03-04
JPS5626661B2 (US20090192370A1-20090730-C00001.png) 1981-06-19
AU5983573A (en) 1975-03-06
FR2197598B1 (US20090192370A1-20090730-C00001.png) 1977-07-15
IE38141L (en) 1974-02-28
DD109628A5 (US20090192370A1-20090730-C00001.png) 1974-11-12
US3925395A (en) 1975-12-09
IE38141B1 (en) 1978-01-04

Similar Documents

Publication Publication Date Title
JPS5751733B2 (US20090192370A1-20090730-C00001.png)
FR2201369A1 (US20090192370A1-20090730-C00001.png)
FR2197598B1 (US20090192370A1-20090730-C00001.png)
JPS4980976A (US20090192370A1-20090730-C00001.png)
FR2190786B3 (US20090192370A1-20090730-C00001.png)
JPS5353363Y2 (US20090192370A1-20090730-C00001.png)
JPS5225057Y2 (US20090192370A1-20090730-C00001.png)
RO56362A2 (US20090192370A1-20090730-C00001.png)
JPS49102781U (US20090192370A1-20090730-C00001.png)
JPS48113310U (US20090192370A1-20090730-C00001.png)
JPS4891738A (US20090192370A1-20090730-C00001.png)
BG20480A1 (US20090192370A1-20090730-C00001.png)
BG19955A1 (US20090192370A1-20090730-C00001.png)
CH590895A5 (US20090192370A1-20090730-C00001.png)
CH590850A5 (US20090192370A1-20090730-C00001.png)
CH576329A5 (US20090192370A1-20090730-C00001.png)
CH577010A5 (US20090192370A1-20090730-C00001.png)
BG20008A1 (US20090192370A1-20090730-C00001.png)
CH589681A5 (US20090192370A1-20090730-C00001.png)
CH587301A5 (US20090192370A1-20090730-C00001.png)
CH587255A5 (US20090192370A1-20090730-C00001.png)
CH586692A5 (US20090192370A1-20090730-C00001.png)
CH585688A5 (US20090192370A1-20090730-C00001.png)
CH578290A5 (US20090192370A1-20090730-C00001.png)
NL7211241A (US20090192370A1-20090730-C00001.png)

Legal Events

Date Code Title Description
ST Notification of lapse